Table 4.
Rates of nosocomial infection/ sepsis /100 days by treatment group and immunocompromised status
| IMMUNOCOMPROMISED PATIENTS
| |||
|---|---|---|---|
| Variable | WHEY Group N=11 |
ZSGM Group N=14 |
p-value |
|
| |||
| Total Number of Events (Infection or Sepsis) | 12 | 4 | |
| Total Number of PICU Days | 165 | 217 | |
| Total Number of Study Days | 197 | 255 | |
| Mean No. of Events/Patient/100 Study Days (95% Confidence Interval) | 6.09 (3.33, 10.32) | 1.57 (0.53,3.73) | 0.011 |
| IMMUNE COMPETENT PATIENTS
| |||
|---|---|---|---|
| Variable | WHEY Group N=133 |
ZSGM Group N=135 |
p-value |
|
| |||
| Total Number of Events (Infection or Sepsis) | 104 | 106 | |
| Total Number of PICU Days | 1828 | 1576 | |
| Total Number of Study Days | 2205 | 1950 | |
| Mean No. of Events/Patient/100 Study Days (95% Confidence Interval) | 4.72 (3.87,5.69) | 5.44 (4.47,6.55) | 0.30 |